XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Beginning Balance (in shares) at Sep. 30, 2020   12,404    
Beginning Balance at Sep. 30, 2020 $ 53,437 $ 12 $ 85,868 $ (32,443)
Expense related to director restricted stock unit (shares)   141    
Expense related to director restricted stock units 467   467  
Expense related to employee stock options 1,193   1,193  
Exercise of stock options (shares)   175    
Exercise of stock options 434 $ 1 433  
Net income 10,145     10,145
Cancellation of common stock (in shares)   (6)    
Cancellation of common stock $ (68)   (68)  
Ending Balance (in shares) at Sep. 30, 2021 12,714 12,714    
Ending Balance at Sep. 30, 2021 $ 65,608 $ 13 87,893 (22,298)
Expense related to director restricted stock unit (shares)   0    
Expense related to director restricted stock units 648   648  
Expense related to employee stock options 1,960   1,960  
Stock issued for director restricted stock units (in shares)   53    
Stock issued for director restricted stock units $ 0      
Exercise of stock options (shares) 257 257    
Exercise of stock options $ 637 $ 0 637  
Common stock surrendered for the exercise of stock options (in shares)   (31)    
Common stock surrendered for the exercise of stock options (281)   (281)  
Exercise of stock warrants (in shares)   54    
Exercise of stock warrants 200   200  
Net income $ 23,288     23,288
Ending Balance (in shares) at Sep. 30, 2022 12,714 13,047    
Ending Balance at Sep. 30, 2022 $ 92,060 $ 13 $ 91,057 $ 990